Page last updated: 2024-10-25

diazoxide and Glucosephosphate Dehydrogenase Deficiency

diazoxide has been researched along with Glucosephosphate Dehydrogenase Deficiency in 1 studies

Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.

Glucosephosphate Dehydrogenase Deficiency: A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of GLUCOSE-6-PHOSPHATE DEHYDROGENASE activity in erythrocytes, leading to hemolytic anemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spencer-Peet, J1
Norman, ME1
Lake, BD1
McNamara, J1
Patrick, AD1

Other Studies

1 other study available for diazoxide and Glucosephosphate Dehydrogenase Deficiency

ArticleYear
Hepatic glycogen storage disease. Clinical and laboratory findings in 23 cases.
    The Quarterly journal of medicine, 1971, Volume: 40, Issue:157

    Topics: Child; Child, Preschool; Diazoxide; Diet Therapy; Female; Fructose; Galactose; Glucose Tolerance Tes

1971